Shares of Dong-A, Hanmi boosted by state-led R&D support plan

Published: 2011-08-17 07:00:00

Updated: 2011-08-17 07:00:00

Shares of research-oriented pharmaceutical firms, such as Dong-A Pharmaceutical firm, Hanmi Pharmaceutical, LG Life Sciences and SK Chemicals, were boosted on Friday by expectations that their new drugs may help lift earnings in line with the government’s long-term measures for drug manufacturers...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK